Defactinib

Avutometinib_Defactinib Phase III Confirmatory Study in LGSOC Completes Design

Avutometinib/Defactinib Phase III Confirmatory Study in LGSOC Completes Design

SG Tylor

Source –  Verastem Oncology The FDA and Verastem Oncology have finalized the design of a Phase III clinical trial to ...